Are Analysts Bullish Amedisys, Inc. (NASDAQ:AMED) After Last Week?

Amedisys, Inc. (NASDAQ:AMED) Logo
Investors sentiment decreased to 1.03 in 2019 Q2. Its down 0.03, from 1.06 in 2019Q1. It dived, as 44 investors sold Amedisys, Inc. shares while 81 reduced holdings. 47 funds opened positions while 82 raised stakes. 26.15 million shares or 1.54% less from 26.55 million shares in 2019Q1 were reported.
First Tru Advisors L P holds 30,716 shares. State Common Retirement Fund holds 0.01% or 45,916 shares in its portfolio. Numerixs Inv Tech stated it has 0.05% of its portfolio in Amedisys, Inc. (NASDAQ:AMED). Walleye Trading Ltd Limited Liability Company has invested 0% in Amedisys, Inc. (NASDAQ:AMED). Clarivest Asset Mgmt Limited Liability Corporation has invested 0.24% in Amedisys, Inc. (NASDAQ:AMED). Louisiana State Employees Retirement, a Louisiana-based fund reported 7,500 shares. Legal And General Grp Inc Public Ltd Liability Corporation reported 69,115 shares. 76,449 are held by Amer Intll Grp. Cortina Asset Mgmt Lc has invested 0.62% in Amedisys, Inc. (NASDAQ:AMED). The Switzerland-based Credit Suisse Ag has invested 0% in Amedisys, Inc. (NASDAQ:AMED). Fincl Bank Of America De invested 0.01% of its portfolio in Amedisys, Inc. (NASDAQ:AMED). Quantbot Tech Ltd Partnership has invested 0.02% in Amedisys, Inc. (NASDAQ:AMED). Tennessee-based State Of Tennessee Treasury Department has invested 0.04% in Amedisys, Inc. (NASDAQ:AMED). Schroder Investment Management Group Inc reported 37,864 shares or 0% of all its holdings. Alpine Woods Capital Investors Lc invested 0.4% of its portfolio in Amedisys, Inc. (NASDAQ:AMED).

Amedisys, Inc. (NASDAQ:AMED) Ratings Coverage

Among 3 analysts covering Amedisys (NASDAQ:AMED), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Amedisys has $145 highest and $120 lowest target. $138’s average target is 3.95% above currents $132.75 stock price. Amedisys had 7 analyst reports since March 19, 2019 according to SRatingsIntel. The firm has “Outperform” rating given on Thursday, May 2 by Raymond James. On Thursday, March 21 the stock rating was maintained by Barclays Capital with “Equal-Weight”. The company was maintained on Thursday, March 21 by SunTrust. On Monday, August 5 the stock rating was maintained by Barclays Capital with “Equal-Weight”. As per Monday, July 15, the company rating was maintained by Raymond James. Below is a list of Amedisys, Inc. (NASDAQ:AMED) latest ratings and price target changes.

05/08/2019 Broker: Barclays Capital Rating: Equal-Weight Old Target: $120.0000 New Target: $125.0000 Maintain
15/07/2019 Broker: Raymond James Rating: Outperform Old Target: $140.0000 New Target: $144.0000 Maintain
06/06/2019 Broker: BidaskScore Rating: Hold Upgrade
02/05/2019 Broker: Raymond James Old Rating: Market Perform New Rating: Outperform New Target: $140.0000 Upgrade
21/03/2019 Broker: SunTrust Rating: Buy New Target: $145 Maintain
21/03/2019 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Equal-Weight Old Target: $115 New Target: $120 Maintain
19/03/2019 Broker: Oppenheimer Rating: Buy Maintain

The stock increased 0.84% or $1.1 during the last trading session, reaching $132.75. About 207,498 shares traded. Amedisys, Inc. (NASDAQ:AMED) has risen 47.57% since September 13, 2018 and is uptrending. It has outperformed by 47.57% the S&P500.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. The company has market cap of $4.27 billion. It operates through three divisions: Home Health, Hospice, and Personal Care. It has a 35.2 P/E ratio. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

More notable recent Amedisys, Inc. (NASDAQ:AMED) news were published by: Finance.Yahoo.com which released: “Can Amedisys, Inc. (NASDAQ:AMED) Maintain Its Strong Returns? – Yahoo Finance” on August 05, 2019, also Globenewswire.com with their article: “Amedisys Celebrates More Than 7000 Nurses During National Nurses Week – GlobeNewswire” published on May 06, 2019, Finance.Yahoo.com published: “Read This Before Buying Amedisys, Inc. (NASDAQ:AMED) Shares – Yahoo Finance” on July 17, 2019. More interesting news about Amedisys, Inc. (NASDAQ:AMED) were released by: Nasdaq.com and their article: “Here’s Why You Should Hold on to Ecolab (ECL) Stock Now – Nasdaq” published on September 12, 2019 as well as Nasdaq.com‘s news article titled: “Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year? – Nasdaq” with publication date: August 16, 2019.

Amedisys, Inc. (NASDAQ:AMED) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.